Tumor Test Marker YRA385 // YRA391

The Tumor Test Marker YRA385 // YRA391 is an innovative solution that facilitates early cancer detection by identifying elevated tumor marker levels in the bloodstream. Designed for chemiluminescence immunoassay (CLIA) analyzers, this comprehensive test kit detects 18 distinct tumor markers, providing crucial insights for diagnosing various malignant tumors. Certified with CE, ISO13485, and FSC approvals, it ensures reliability and accuracy in testing. The kit supports a range of models from YRA385 to YRA391, focused on parameters such as AFP, CEA, CA125, among others, and operates on an alkaline phosphatase platform.

Market Price

The pricing for tumor marker test kits like the Tumor Test Marker YRA385 // YRA391 varies, typically ranging from $300 to $800 per box, depending on the number of tests included and the supplier. For precise pricing and to explore potential bulk purchase discounts, users are encouraged to request a quote or take advantage of the automated quotation system through the Kalstein Plus platform.

Frequently Asked Questions

What tumor markers does the kit detect? The kit detects 18 different tumor markers, including AFP, CEA, and CA125.

Is the kit certified for clinical use? Yes, it is certified with CE, ISO13485, and FSC standards.

How is it packaged? The kits are available in packages of 50, 100, or 24 tests per box.

Advantages and Disadvantages

Advantages: High sensitivity and specificity due to its CLIA technology, easy integration into existing lab workflows, and comprehensive detection of multiple tumor markers in a single test.

Disadvantages: Requires investment in compatible CLIA analyzers and proper storage conditions to maintain efficacy.

Product Use in the Field

In clinical settings, the Tumor Test Marker YRA385 // YRA391 is employed to detect and monitor tumor markers in patients, aiding in early diagnosis and ongoing management of cancer. Its multiparametric capabilities allow healthcare professionals to obtain a more holistic view of a patient’s oncological status during routine blood tests.

Recommendations

To ensure optimal results, it’s recommended to store the kits within the specified temperature range of 2-8°C. Regular calibration of the analyzers should be performed using the provided 2 or 6-point calibration options to maintain accuracy and reliability in test outcomes.

Features

• Detects 18 tumor markers
• CE, ISO13485, FSC certified
• Compatible with CLIA analyzers
• Includes models from YRA385 to YRA391

Technical Specifications